Prostate cancer prevention: review of target populations, pathological biomarkers, and chemopreventive agents

J Clin Pathol. 1999 Nov;52(11):793-803. doi: 10.1136/jcp.52.11.793.

Authors

R Montironi¹, R Mazzucchelli, J R Marshall, P H Bartels

Affiliation

¹ Institute of Pathological Anatomy and Histopathology, University of Ancona, Ospedale Regionale, Italy. [email protected]

No abstract available

Publication types

Review

MeSH terms

Adenocarcinoma / diagnosis
Adenocarcinoma / genetics
Adenocarcinoma / prevention & control*
Androgen Antagonists / therapeutic use
Animals
Antineoplastic Agents / therapeutic use
Clinical Trials as Topic
Diet
Disease Models, Animal
Eflornithine / therapeutic use
Genetic Predisposition to Disease
Humans
Male
Prostatic Intraepithelial Neoplasia / diagnosis
Prostatic Neoplasms / diagnosis
Prostatic Neoplasms / genetics
Prostatic Neoplasms / prevention & control*
Retinoids / therapeutic use

Substances

Androgen Antagonists
Antineoplastic Agents
Retinoids
Eflornithine